21 May 2026 -- Chapel-en-le-Frith, UK and California, US -- Concept Life Sciences, a leading global contract research organization with expertise in integrated drug discovery and development, and OpenBench, a pioneer of success-based AI hit discovery, today announced a strategic partnership to accelerate hit identification for biotech companies through a fee-for-success model.

20 May 2026 -- Basel, Switzerland, and Oxford, UK -- Oxford Nanopore Technologies, a company delivering a new generation of nanopore-based molecular sensing technology, and Lonza today announced the launch of a new technology approach designed to modernize and accelerate GMP quality control testing for mRNA therapeutics.

19 May 2026 -- Oxford, UK -- IKA’s new generation of magnetic stirrers incorporates state-of-the-art smart features, setting the new global standards for efficiency, safety, and reliability.

19 May 2026 -- Stockholm, Sweden -- Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced an agreement with the National Genomics Infrastructure (NGI), one of the largest technical platforms at SciLifeLab.

19 May 2026 -- Paris, France and Manchester, UK -- Yourgene Health, an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces the launch of Yourgene Insight DPYD assay, an assay utilising genetic insights for safer chemotherapy treatments to align with updated testing guidelines.

18 May 2026 -- Espoo, Finland -- Medix Biochemica, a leading, global supplier of critical components for the in vitro diagnostics industry, today announced a Board-approved $5 million investment to expand its recombinant antigen and cell culture technology capabilities across its Espoo, Finland and St. Louis, Missouri facilities.

11 May 2026 -- Cambridge, UK and Massachusetts, US -- Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its antibody screening service to streamline the transition from antibody hit generation to lead selection.

6 May 2026 — Bubendorf, Switzerland — CARBOGEN AMCIS has launched SPRINT, a dedicated approach to early-phase drug substance development designed to deliver faster, more efficient progression to clinical phases without compromising scientific rigour.

6 May 2026 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, today announces that its Shanghai facility has successfully completed an unannounced Good Manufacturing Practice (GMP) inspection by China’s National Medical Products Administration (NMPA), with no observations.

5 May 2025 -- California, US -- Bio-Rad Laboratories, Inc, a global leader in life science research and clinical diagnostics products, today announced the expansion of its TrailBlazer StarBright Dye Label Kits, offering a convenient method for conjugating antibodies to premium fluorophores.

5 May 2026 -- Singapore, Singapore -- Hongene Biotech Corporation today announced its support of SiranBio’s SA1211 program, a dual-target siRNA candidate for chronic hepatitis B, underscoring Hongene’s ability to deliver end-to-end development and manufacturing solutions for structurally complex oligonucleotide therapeutics.

30 April 2026 -- Silverstone, UK -- Lab Thread Ltd, a UK-based life science software company, today announced the worldwide commercial release of its Unified Lab Software Platform.